Myra Hi Myra, I would not worry too much about the topical cream
Network meta-analysis of treatments for type 2 diabetes mellitus following failure with metformin plus sulfonylurea
Peeva Jul 26, 2024 5 min read Updated: Oct 1, 2024 Semaglutide injections are a powerful new tool for weight loss, offering significant results for many patients in Sacramento and beyond
Patients receiving OZEMPIC in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia
Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist licensed for weight management in UK adults with BMI 30 kg/m or 27 kg/m with comorbidities
None are FDA-approved for human use, and this article reports documented protocols for research models, not medical advice